Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gentile

Showing results (71-80 of 313) with videos related to

Pageof 32
Sort By:
European Journal of Haematology|July 27, 2025
Vaccination in Multiple Myeloma: Challenges and StrategiesEnrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
Expert Opinion on Pharmacotherapy|October 10, 2024
The role of corticosteroids in the current treatment paradigm for myelofibrosisAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|November 26, 2025
Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention StrategiesEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
European Journal of Haematology|September 13, 2025
Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options?Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Cancer|April 22, 2011
The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimensGiulia Benevolo, Alessandra Larocca, Massimo Gentile, et al.
Expert Opinion on Investigational Drugs|April 5, 2013
Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myelomaMassimo Martino, Attilio Olivieri, Massimo Offidani, et al.
Expert Opinion on Investigational Drugs|March 3, 2015
Promising therapies for the treatment of chronic lymphocytic leukemiaFortunato Morabito, Anna Grazia Recchia, Ernesto Vigna, et al.
Cancer Research|April 6, 2006
Cannibalism of live lymphocytes by human metastatic but not primary melanoma cellsLuana Lugini, Paola Matarrese, Antonella Tinari, et al.
Journal of Medical Virology|February 22, 2007
Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, ItalyAlessandra Pierangeli, Massimo Gentile, Paola Di Marco, et al.
Haematologica|December 23, 2003
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized studyFrancesca R Mauro, Pierluigi Zinzani, Francesco Zaja, et al.
Pageof 32

Showing results (71-80 of 313) with videos related to

Sort By:
Pageof 32
European Journal of Haematology|July 27, 2025
Vaccination in Multiple Myeloma: Challenges and StrategiesEnrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
Expert Opinion on Pharmacotherapy|October 10, 2024
The role of corticosteroids in the current treatment paradigm for myelofibrosisAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|November 26, 2025
Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention StrategiesEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
European Journal of Haematology|September 13, 2025
Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options?Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Cancer|April 22, 2011
The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimensGiulia Benevolo, Alessandra Larocca, Massimo Gentile, et al.
Expert Opinion on Investigational Drugs|April 5, 2013
Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myelomaMassimo Martino, Attilio Olivieri, Massimo Offidani, et al.
Expert Opinion on Investigational Drugs|March 3, 2015
Promising therapies for the treatment of chronic lymphocytic leukemiaFortunato Morabito, Anna Grazia Recchia, Ernesto Vigna, et al.
Cancer Research|April 6, 2006
Cannibalism of live lymphocytes by human metastatic but not primary melanoma cellsLuana Lugini, Paola Matarrese, Antonella Tinari, et al.
Journal of Medical Virology|February 22, 2007
Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, ItalyAlessandra Pierangeli, Massimo Gentile, Paola Di Marco, et al.
Haematologica|December 23, 2003
Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized studyFrancesca R Mauro, Pierluigi Zinzani, Francesco Zaja, et al.
Pageof 32